The present invention relates to the use of 2-oxo-1-pyrrolidine derivatives (and in particular (S)-(-)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamide) for t he preparation of drugs for the curative and/or prophylactic treatment of dyskinesia
USE OF 2-OXO-1-PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF DYSKINESIA AND MOVEMENT DISORDERS